415 Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Vesper Medicalvespermedical.comin𝕏May 2019
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)Neil Hattangadi(Director)Peter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareLightstone VenturesVensana Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.